A pharmaceutical company with Capital Region ties is involved in President Donald Trump’s COVID-19 treatment.
Regeneron Pharmaceuticals, which has a supply location in Rensselaer, confirmed Friday that it has supplied the president with an 8-gram dose of the REGN-COV2 antibody cocktail. Commander Sean Conley, the president’s physician, first stated Friday that Trump had been given the dose of the cocktail, what Regeneron refers to as “an investigational COVID-19 therapy.”
Trump, who has been taken to Walter Reed Medical Center as a precaution, is also "taking zinc, vitamin D, famotidine, melatonin and a daily aspirin," per the statement from Conley.
"REGN-COV2 is being evaluated for both the treatment and prevention of COVID-19," according to Regeneron's statement. "Clinical trials are actively enrolling hospitalized and non-hospitalized patients, as well as people at risk of infection who have had close household exposure to a COVID-19 patient. Earlier this week, Regeneron announced early data showing a reduction in viral levels and improved symptoms with REGN-COV2 treatment in non-hospitalized COVID-19 patients."